Miltefosine

Description du produit

Miltefosine is a pharmaceutical substance for the treatment of parasite-induced leishmaniasis. It is used in human and veterinary medicines and is taken orally in the form of tablets.

Comprehensive documentation for drug registration of Miltefosine can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
58066-85-6 ASMF IH

Tradename(s)

Miltefosine (Antileishmanial)

Disponibilité pays

Disponible dans le monde entier

Marta Ackermann

Interlocuteur

Marta Ackermann

Sales Manager


email   phone